Manlhiot, C, Menjak, IB, Brandao, LR, et al. Risk, clinical features, and outcomes of thrombosis associated with pediatric cardiac surgery. Circulation
2011; 124: 1511–1519.
Manlhiot, C, Brandao, LR, Schwartz, SM, et al. Management and outcomes of patients with occlusive thrombosis after pediatric cardiac surgery. J Pediatr
2016; 169: 146–153.
Ansah, DA, Patel, KN, Montegna, L, Nicholson, GT, Ehrlich, AC, Petit, CJ. Tissue plasminogen activator use in children: bleeding complications and thrombus resolution. J Pediatr 2015; 171: 67–72.
Monagle, P, Chan, AK, Goldenberg, NA, et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest
2012; 141: e737S–e7801.
Demaerschalk, BM, Kleindorfer, DO, Adeoye, OM, et al. Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke
2016; 47: 581–641.
Yee, DL, Chan, AK, Williams, S, Goldenberg, NA, Massicotte, MP, Raffini, LJ. Varied opinions on thrombolysis for venous thromboembolism in infants and children: findings from a survey of pediatric hematology-oncology specialists. Pediatr Blood Cancer
2009; 53: 960–966.
Bratincsak, A, Moore, JW, El-Said, HG. Low dose tissue plasminogen activator treatment for vascular thrombosis following cardiac catheterization in children: a single center experience. Catheter Cardiovasc Interv
2013; 82: 782–785.
Wang, M, Hays, T, Balasa, V, et al. Low-dose tissue plasminogen activator thrombolysis in children. J Pediatr Hematol Oncol
2003; 25: 379–386.
Santiago, MJ, Lopez-Herce, J, Zarzoso, S, Sanchez, A, Mencia, S, Carrillo, A. [Thrombolytic therapy using a low dose of issue plasminogen activator in children]. An Pediatr
2012; 76: 77–82.
Leary, SE, Harrod, VL, de Alarcon, PA, Reiss, UM. Low-dose systemic thrombolytic therapy for deep vein thrombosis in pediatric patients. J Pediatr Hematol Oncol
2010; 32: 97–102.
Canan Hasanoglu, H, Hezer, H, Karalezli, A, et al. Half-dose recombinant tissue plasminogen activator treatment in venous thromboembolism. J Investig Med
2014; 62: 71–77.
Cable, DG, Cherry, KJ. Systemic thrombolytic therapy after recent abdominal aortic aneurysm repair: an absolute contraindication?
Mayo Clinic Proc
2003; 78: 99–102.
Pilloud, J, Rimensberger, PC, Humbert, J, Berner, M, Beghetti, M. Successful local low-dose urokinase treatment of acquired thrombosis early after cardiothoracic surgery. Pediatr Crit Care Med
2002; 3: 355–357.
Borasino, S, Diaz, F, El Masri, K, Dabal, RJ, Alten, JA. Central venous lines are a risk factor for chylothorax in infants after cardiac surgery. World J Pediatr Congenit Heart Surg
2014; 5: 522–526.
Wright, JM, Watts, RG. Venous thromboembolism in pediatric patients: epidemiologic data from a pediatric tertiary care center in Alabama. J Pediatr Hematol Oncol
2011; 33: 261–264.
Mery, CM, Moffett, BS, Khan, MS, et al. Incidence and treatment of chylothorax after cardiac surgery in children: analysis of a large multi-institution database. J Thorac Cardiovasc Surg
2014; 147: 678–86.e1; discussion: 85–86.
Alkayed, K, Plautz, G, Gowans, K, Rosenthal, G, Soldes, O, Qureshi, AM. Chylopericardium and chylothorax: unusual mechanical complications of central venous catheters. Pediatr Int
2013; 55: e4–e6.
Biewer, ES, Zurn, C, Arnold, R, et al. Chylothorax after surgery on congenital heart disease in newborns and infants -risk factors and efficacy of MCT-diet. J Cardiothorac Surg
2010; 5: 127.
Bauman, ME, Moher, C, Bruce, AK, Kuhle, S, Kaur, S, Massicotte, MP. Chylothorax in children with congenital heart disease: incidence of thrombosis. Thromb Res
2013; 132: e83–e85.
Soto-Martinez, M, Massie, J. Chylothorax: diagnosis and management in children. Paediatr Respir Rev
2009; 10: 199–207.
Chan, EH, Russell, JL, Williams, WG, Van Arsdell, GS, Coles, JG, McCrindle, BW. Postoperative chylothorax after cardiothoracic surgery in children. Ann Thorac Surg
2005; 80: 1864–1870.
Carrier, M, Righini, M, Djurabi, RK, et al. VIDAS D-dimer in combination with clinical pre-test probability to rule out pulmonary embolism. A systematic review of management outcome studies. Thromb Haemost
2009; 101: 886–892.
Di Nisio, M, Squizzato, A, Rutjes, AW, Buller, HR, Zwinderman, AH, Bossuyt, PM. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review. J Thromb Haemost
2007; 5: 296–304.
Wells, PS, Anderson, DR, Rodger, M, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. New Engl J Med
2003; 349: 1227–1235.
Hanslik, A, Thom, K, Haumer, M, et al. Incidence and diagnosis of thrombosis in children with short-term central venous lines of the upper venous system. Pediatrics
2008; 122: 1284–1291.
Le Gal, G, Righini, M. Controversies in the diagnosis of venous thromboembolism. J Thromb Haemost
2015; 13 (Suppl 1): S259–S265.